Jonathan W Lee

58 posts

Jonathan W Lee

@Jonathanwlee23

Chief Heme/Onc Fellow at Weill Cornell Medicine Former NYU Internal Medicine | Oxford University | UIC GPPA

New York, USA Katılım Haziran 2024

181 Takip Edilen128 Takipçiler

Jonathan W Lee retweetledi

Wungki Park, MD MS@CentralParkWMD·20 Mar

#RAS #revolution in first line chemo combo with gemcitabine and nab-paclitaxel backbone, the preview for ongoing registrational RASolute 303 study #KRAS #PDAC @MSK_DeptOfMed @MSKCancerCenter

KRAS Kickers@KRASKickers

#KRASatAACR26 LB407 / 7 - Daraxonrasib plus chemotherapy (CT) as first-line (1L) treatment for patients (Pts) with metastatic pancreatic adenocarcinoma (mPDAC) April 21 MiniSymposium: Late-Breaking Research abstractsonline.com/pp8/?fbclid=Iw… @AACR @CentralParkWMD @aparna1024 #KRAS #AACR26

English

Jonathan W Lee@Jonathanwlee23·21 Şub

@Jani_Chinmay @OncLive @sitcancer @FionnualaCrowle @BenBleibergMD amazing friends and amazing oncologists -- looking forward to many years of friendship and collaboration 🤗

English

Chinmay Jani@Jani_Chinmay·19 Şub

What started as an acquaintance at the @OncLive workshop 2 years back - has now grown into a collaboration and friendship - and now we keep running into each other at conferences all the time! 😊 @sitcancer Winter School! @FionnualaCrowle @BenBleibergMD @Jonathanwlee23 - you were missed! @BenBleibergMD - next stop TTLC @IASLC

English

4.5K

Jonathan W Lee@Jonathanwlee23·10 Şub

Really enjoying working on this series with @Jani_Chinmay on advice for medical trainees as they navigate an increasingly complex landscape of medical education. We're discussing research, conferences, mentorship, and much more. Thanks to @ginacolumbusonc and @CancerNetwrk for the opportunity and platform to discuss these important topics. Stay tuned for more! #MedEd #Oncology #Cancer

Chinmay Jani@Jani_Chinmay

Thrilled to share this new video series that @Jonathanwlee23 and I have started, with our latest Career Center video now live on @CancerNetwrk : Participating in Research During Residency. We discuss practical strategies for balancing clinical work with research, finding mentors, presenting at conferences, and seizing new opportunities. @SylvesterCancer @WeillCornell 🎥 Watch here: tinyurl.com/4ct5h7xr

English

1.5K

Jonathan W Lee@Jonathanwlee23·25 Oca

@Jani_Chinmay @gotoPER @EddieSantosMD @JuliaRotow @BrunaPellini @LuisRaezMD @DocOncMD @Latinamd @GlopesMd Amazing work Chinmay, looking forward to catching you at the next one!

English

438

Chinmay Jani@Jani_Chinmay·24 Oca

Thanks to the organizers for inviting me to present at 23rd #WinterLung @gotoPER Discussed a case focusing on ctDNA monitoring in lung cancer, including tumor-informed vs agnostic approaches and methylation- vs VAF-based tracking alongside imaging. Strong concordance with radiologic scans observed. Prospective studies will guide future decision-making. Grateful to the powerful panel for detailed discussion. @SylvesterCancer @HemOncMiami #LungCancer #ctDNA #LiquidBiopsy #PrecisionOncology

English

1.7K

Jonathan W Lee@Jonathanwlee23·24 Oca

A fun article I wrote with @OncLive reflecting on how I approached interviews for heme/onc fellowship. Looking forward to breaking this down further in future editions! 📖

OncLive.com@OncLive

A Guide to Interviewing for Hematology/Oncology Fellowship From a Chief Fellow @Jonathanwlee23 @WeillCornell #oncology #oncologyfellowship hubs.li/Q0409_bC0

English

399

Jonathan W Lee@Jonathanwlee23·23 Oca

Excited to share our recent publication looking at PD-L1 as a predictive biomarker to Osimertinib therapy in 1L EGFR-mt NSCLC (N=101) doi.org/10.1016/j.ctar… 🎯PD-L1 ≥1% had lower RR, PFS, and OS 🧬?What does PD-L1 expression represent beyond immune evasion, especially in the context of EGFR-mt? 🧑‍🔬Stay tuned for an ongoing international collaboration to explore these questions! @DrAshish_Saxena @christinemphmd @StephanieBogda5 @WCMHemOncFellow

English

3.2K

Wungki Park, MD MS@CentralParkWMD·10 Oca

Congrats 🎊Jonathan for joining @StanfordCancer Mentor-mentee 🧑‍🎓🏫 relationship is so special and precious! 💎 Looking forward to future 🗺️collaboration! @ASCO #GI26 @EileenMOReilly @CentralParkWMD @Jonathanwlee23

English

2.4K

Jonathan W Lee@Jonathanwlee23·10 Oca

@CentralParkWMD @StanfordCancer @ASCO @EileenMOReilly @MSKCancerCenter Looking forward to continued learning and research collaborations with you and your team Dr Park and Dr O’Reilly!

English

237

Jonathan W Lee retweetledi

OncLive.com@OncLive·9 Oca

The potential of an oral monotherapy treatment in #pdac . Much needed hope and promise for such a devastating disease. Looking forward to more mature survival data, response durability with ctDNA correlates, and the read outs of ongoing clinical trials for pan RAS and allele-specific inhibitors. Great work presented by Dr Zev Wainberg and colleagues. @Jonathanwlee23 #GI26 #MedTwitter #Oncology

English

436

Jonathan W Lee retweetledi

OncLive.com@OncLive·9 Oca

Happy to be back for another X takeover here at GI ASCO 2026 #GI26 Follow along for a day of learning and meeting some of the luminaries that push science forward in the fight against #cancer @Jonathanwlee23 #HemOncFellows #Oncology #MedTwitter

English

1.3K

Jonathan W Lee retweetledi

Binaytara@binaytara·26 Kas

This #PancreaticCancer Awareness Month, Dr. Jonathan W. Lee of @WeillCornell shares groundbreaking research on PALB2 mutations, one of the few genomically actionable targets in pancreatic cancer: buff.ly/1P9zGsM #HemOnc #MedX #MedTwitter

English

301

Jonathan W Lee@Jonathanwlee23·18 Kas

Check out this article where I discuss some of the unmet needs in #PancreaticCancer including early detection, actionable genomic alterations, and promising agents currently under clinical investigation. Great time speaking with the #Binaytara group! binaytara.org/cancernews/art… #CancerResearch

English

191

Jonathan W Lee@Jonathanwlee23·15 Kas

Great time chatting about lung cancer with Dr @benlevylungdoc at #CFS. Many exciting developments in the targeted and perioperative spaces 👌

OncLive.com@OncLive

Yesterday at CFS, @benlevylungdoc sat down with @Jonathanwlee23 to break down the evolving treatment landscape for EGFR-mutant and HER2-positive lung cancer. 🧬💡🫁 👉 Tune in to hear their insights on our latest episode of #OncLiveOnAir hubs.li/Q03TlYdf0

English

266

Jonathan W Lee retweetledi

OncLive.com@OncLive·13 Kas

🎙️🗽 Our final recording of the day is underway at CFS 2025! In this episode, @benlevylungdoc sits down with @Jonathanwlee23 for a special #OncLiveOnAir live recording on evolving care for HER2- and EGFR-positive #NSCLC. 🎧✨ Tune in tomorrow to watch the full episode! onclive.com/podcasts

English

673

Jonathan W Lee retweetledi

Isabel Preeshagul@ipreeshagul·13 Kas

I had the privilege of learning from these brilliant fellows as we dissected abstracts from @ASCO @IASLC @myESMO Main 👇🏽 ✴️we need to personalize tx in neoadjuvant setting as we do in metastatic ie: ngs ✴️ ⬆️work needs to be done in stg 4 2nd line ✴️ is more better? $ Tox

English

2.2K

Jonathan W Lee retweetledi

CancerNetwork®@CancerNetwrk·24 Eki

Third-year fellows from Weill Cornell Medicine offer 7 key tips for establishing a foundational understanding of the field at major oncology meetings. Read them here: hubs.li/Q03PNrXh0 #cancer #oncology | @Jonathanwlee23 @TAkhlagh @WeillCornell

English

375

Michael May@MichaelMayMD·21 Eki

Tremendous thanks to our many collaborators @christinemphmd and @Jonathanwlee23 at @WCMLungCancer, @KCArbourMD Gregory Reily and Stephanie Bogdan at @MSKCancerCenter @DrDawnHershman @BHenickMD @CatherineShuMD and Ben May at @columbiacancer and and many others.

English

579

Jonathan W Lee@Jonathanwlee23·21 Eki

@MichaelMayMD @christinemphmd @WCMLungCancer @KCArbourMD @MSKCancerCenter @DrDawnHershman @BHenickMD @CatherineShuMD @columbiacancer A very important and timely topic -- great collaborating with you!

English

Michael May@MichaelMayMD·21 Eki

academic.oup.com/jnci/advance-a… We found that 60-70% of patients in a real world cohort of KRAS G12C mutant NSCLC would have been ineligible for trials of KRAS G12C inhibitors including most patients who received these therapeutics after their approval. @bherzbergmd @margaux_wooster

English

256

Jonathan W Lee@Jonathanwlee23·19 Eki

Attending the #BTGGlobalLung2025 meeting was an incredible experience. High level discussion with international perspective to understand, integrate, and adapt data across the continuum of lung cancer. Highly encourage all trainees to get involved with @ASCO @myESMO @OncLive for opportunities like this. Appreciate all the faculty who gave guidance and career advice to a brand new (technically unborn) oncologist!

English

1.5K

Keşfet

@MSK_DeptOfMed @MSKCancerCenter @Jani_Chinmay @OncLive @sitcancer @FionnualaCrowle @BenBleibergMD @IASLC